Shared immunoproteome for ovarian cancer diagnostics and immunotherapy: potential theranostic approach to cancer.
about
Beyond CA125: the coming of age of ovarian cancer biomarkersIn 2014, can we do better than CA125 in the early detection of ovarian cancer?Antigen-specific immunotherapy of cervical and ovarian cancerProteome serological determination of tumor-associated antigens in melanoma.Proteome-based analysis of serologically defined tumor-associated antigens in cutaneous lymphomaSeromic profiling of ovarian and pancreatic cancer.Identification of three new autoantibodies associated with systemic lupus erythematosus using two proteomic approachesTumor-associated autoantibody signature for the early detection of gastric cancer.Exploring the immunoproteome for ovarian cancer biomarker discovery.Autoantibody signature for the serologic detection of ovarian cancerPeptidomics analysis of human blood specimens for biomarker discovery.The impact of T-cell immunity on ovarian cancer outcomes.Ovarian cancer biomarkers: a focus on genomic and proteomic findings.An outlook on ovarian cancer and borderline ovarian tumors: focus on genomic and proteomic findingsA systematic review of humoral immune responses against tumor antigens.Early Detection of Cancer: Immunoassays for Plasma Tumor Markers.Autoantibodies in cancer: prognostic biomarkers and immune activation.Secreted tumor antigens - immune biomarkers for diagnosis and therapy.Proteomic analysis of human epithelial ovarian cancer xenografts in immunodeficient mice exposed to chronic psychological stress.
P2860
Q24651567-74DEC691-EBE6-4F15-8ECB-ABA708A3780DQ26825152-6334FCC9-ED67-4C55-86EE-097544518CB8Q27488697-7E3F303E-8381-4529-B505-3A17EFA810B3Q33432732-58E675DF-84B7-49C4-A6C0-BB8AC307A363Q33519571-4E0665C9-D21A-4AE1-BD80-18BBD252A6F1Q33739967-41AE0A7F-1A59-4427-B00B-349FCB9F62BCQ33865598-CAE6A3DA-A51F-41D5-8647-2281B5888751Q34299043-9856C47F-F5CC-4C96-9E3F-BC120822C4C1Q34578119-7505EC2B-8968-4DA9-BB1F-E1DE023D347EQ35100846-40538F41-8281-48B8-835B-80D9C29BFE9FQ36950443-12EBAC54-2616-4921-AE8D-6FBCE8450D95Q37118142-C469B03E-9997-4BA3-877F-13A45F222987Q37119992-82FE8893-2D93-46B2-B7EE-E459AE9C27A6Q37260040-3535AB46-EE6E-4DA8-84AF-501AFE7EAAEDQ37435862-6F74AA5E-0D6C-43F1-BADE-A64E9414B785Q37460195-C69D1CA1-F101-4290-B14C-E6945C95EC0DQ37945787-BD49A598-4B7C-4FB9-ADA3-30A05F26D4ACQ39438407-577BDCFD-B8FC-43DB-92A3-CB4B9291D0FFQ39592859-A58D20FA-0399-44DD-A2F1-D8E8FC5A3F54
P2860
Shared immunoproteome for ovarian cancer diagnostics and immunotherapy: potential theranostic approach to cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Shared immunoproteome for ovar ...... heranostic approach to cancer.
@en
type
label
Shared immunoproteome for ovar ...... heranostic approach to cancer.
@en
prefLabel
Shared immunoproteome for ovar ...... heranostic approach to cancer.
@en
P2093
P2860
P356
P1476
Shared immunoproteome for ovar ...... heranostic approach to cancer.
@en
P2093
Gomathinayagam Sinnathamby
Jennifer Zerfass
Jonathan Krakover
Lorraine Keller
Mohan Philip
Ramila Philip
Sidhartha Murthy
P2860
P304
P356
10.1021/PR0606777
P577
2007-06-05T00:00:00Z